CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Nature Cell Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ncb2139PMID 21131960PMCID PMC3076036
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2

  2010cited by this paper
• Phosphorylation dynamics during early differentiation of human embryonic stem cells.

  2009cited by this paper
• Unraveling the human embryonic stem cell phosphoproteome.

  2009cited by this paper
• Down-regulation of Enhancer of Zeste-2 decreases growth of estrogen receptor negative invasive breast carcinoma and requires BRCA1

  2008cited by this paper
• A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen.

  2006cited by this paper
• Polycomb complexes repress developmental regulators in murine embryonic stem cells

  2006cited by this paper
• EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast.

  2006cited by this paper
• Control of developmental regulators by Polycomb in human embryonic stem cells.

  2006cited by this paper
• Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions.

  2006cited by this paper
• The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3.

  2004cited by this paper
• Mesenchymal stem cells: clinical applications and biological characterization.

  2004cited by this paper
• EZH2 is downstream of the pRB‐E2F pathway, essential for proliferation and amplified in cancer

  2003cited by this paper
• EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

  2003cited by this paper
• Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing

  2002cited by this paper
• Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein.

  2002cited by this paper
• The polycomb group protein EZH2 is involved in progression of prostate cancer

  2002cited by this paper
• Methylation of Histone H4 at Arginine 3 Facilitating Transcriptional Activation by Nuclear Hormone Receptor

  2001cited by this paper
• 2,6,9-trisubstituted purines: optimization towards highly potent and selective CDK1 inhibitors.

  1999cited by this paper
• Multilineage potential of adult human mesenchymal stem cells.

  1999cited by this paper
• Chondrogenic Differentiation of Cultured Human Mesenchymal Stem Cells from Marrow

  1998cited by this paper
• Osteogenic differentiation of purified, culture‐expanded human mesenchymal stem cells in vitro

  1997cited by this paper
• Lymphocyte activation

  1994cited by this paper
• Distinct roles for cyclin-dependent kinases in cell cycle control.

  1993cited by this paper
• IKKb Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway

  year unknowncited by this paper

• Evaluation of Acoustic Characteristics of Voice Before and After Bariatric Surgery.

  2026cites this paper
• Recent Advances in Bone Tissue Engineering: Enhancing the Potential of Mesenchymal Stem Cells for Regenerative Therapies

  2025cites this paper
• Small cell lung carcinoma with YAP1 expression and SMARCA4-deficient undifferentiated tumors

  2025cites this paper
• ABL Kinases Modulate EZH2 Phosphorylation and Signaling in Metastatic Triple Negative Breast Cancer

  2025influential citation
• Maternal obesity alters histone modifications mediated by the interaction between EZH2 and AMPK, impairing neural differentiation in the developing embryonic brain cortex

  2025cites this paper
• PRMT7-Mediated PTEN Activation Enhances Bone Regeneration in Female Mice

  2025cites this paper
• Mapping Context-Aware Phosphosite Regulation of Protein-Protein Interactions Using Deep Learning and Pan-Cancer Proteomics

  2025cites this paper
• Bidirectional regulation factor of bone marrow mesenchymal stromal cells differentiation: a focus on bone-fat balance in osteoporosis

  2025cites this paper
• Inhibition of miR-615-3p enhances dentinogenesis in scaps via PVT1-mediated mitochondrial regulation

  2025cites this paper
• Mechanistic insights into bone destruction in multiple myeloma: Cellular and molecular perspectives

  2025cites this paper
• Longitudinal Proteomic Profiling of T Cell Differentiation In Vivo Reveals Biochemical Remodeling Underlying Exhaustion

  2025cites this paper
• Revitalizing mesenchymal stem cells: Mechanisms of aging and role of herbal preconditioning in combating senescence

  2025cites this paper
• Phosphorylation of CBX8 by PKD1 suppresses PRC1 activity and promotes cell senescence

  2025cites this paper
• The molecular basis of cell memory in mammals: The epigenetic cycle

  2024cites this paper
• FLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemia

  2024cites this paper
• The Activation of the NF-κB Pathway in Human Adipose-Derived Stem Cells Alters the Deposition of Epigenetic Marks on H3K27 and Is Modulated by Fish Oil

  2024cites this paper
• Fish Oil Supplementation Mitigates High-Fat Diet-Induced Obesity: Exploring Epigenetic Modulation and Genes Associated with Adipose Tissue Dysfunction in Mice

  2024cites this paper
• EZH2 inhibition induces senescence via ERK1/2 signaling pathway in multiple myeloma

  2024cites this paper
• Enriched H3K27Me3 on BMP4 suppresses the osteoblastic differentiation potential of BMSCs in diabetes mellitus.

  2024cites this paper
• Retinoic acid induced specific changes in the phosphoproteome of C17.2 neural stem cells

  2024cites this paper
• Targeting EZH2 attenuates the ferroptosis-mediated osteoblast-osteoclast imbalance in rheumatoid arthritis.

  2024cites this paper
• Significance of targeting DNMT3A mutations in AML

  2024cites this paper
• Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go

  2024cites this paper
• Cell signaling and transcriptional regulation of osteoblast lineage commitment, differentiation, bone formation, and homeostasis

  2024influential citation
• Phosphorylation of EZH2 differs HER2-positive breast cancer invasiveness in a site-specific manner

  2023cites this paper
• EZH2 K63-polyubiquitination affecting migration in extranodal natural killer/T-cell lymphoma

  2023cites this paper
• NFIB–MLL1 complex is required for the stemness and Dlx5-dependent osteogenic differentiation of C3H10T1/2 mesenchymal stem cells

  2023cites this paper
• Protein Kinase Signaling Networks Driven by Oncogenic Gq/11 in Uveal Melanoma Identified by Phosphoproteomic and Bioinformatic Analyses

  2023cites this paper
• Targeting Cyclin‐Dependent Kinase 1 Induces Apoptosis and Cell Cycle Arrest of Activated Hepatic Stellate Cells

  2023cites this paper
• Beyond expression: role of phosphorylated residues of EZH2 in lineage plasticity in prostate cancer.

  2023cites this paper
• Regulation of Osteoblast to Osteocyte Differentiation by Cyclin‐Dependent Kinase‐1

  2023cites this paper
• Unraveling the Missing Link of Bio‐Electrical Stimulation from Body‐Mediated Energy Transfer

  2023cites this paper
• Epigenetic regulation of bone remodeling and its role in the pathogenesis of primary osteoporosis

  2023cites this paper
• Breast cancer patient-derived microtumors resemble tumor heterogeneity and enable protein-based stratification and functional validation of individualized drug treatment

  2023cites this paper
• Biomarkers of aging

  2023cites this paper
• Epigenetics: Novel crucial approach for osteogenesis of mesenchymal stem cells

  2023cites this paper
• Phosphorylation and stabilization of EZH2 by DCAF1/VprBP trigger aberrant gene silencing in colon cancer

  2023cites this paper
• Dysregulation of histone modifications in bone marrow mesenchymal stem cells during skeletal ageing: roles and therapeutic prospects

  2023cites this paper
• Inhibition of Ezh2 redistributes bivalent domains within transcriptional regulators associated with WNT and Hedgehog pathways in osteoblasts

  2023cites this paper
• Multimodal perturbation analyses of cyclin-dependent kinases reveal a network of synthetic lethalities associated with cell-cycle regulation and transcriptional regulation

  2023cites this paper
• Changes in PRC1 activity during interphase modulate lineage transition in pluripotent cells

  2023cites this paper
• Targeting CDK1 in cancer: mechanisms and implications

  2023cites this paper
• G-protein coupled receptor 5C (GPRC5C) is required for osteoblast differentiation and responds to EZH2 inhibition and multiple osteogenic signals.

  2023cites this paper
• Non-canonical functions of EZH2 in cancer

  2023cites this paper
• Epithelial–mesenchymal transition: an organizing principle of mammalian regeneration

  2023cites this paper
• lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma

  2023cites this paper
• Novel insights of EZH2-mediated epigenetic modifications in degenerative musculoskeletal diseases.

  2023cites this paper
• Advances in bi-directional relationships for EZH2 and oxidative stress.

  2023cites this paper
• Phosphorylation and stabilization of PD-L1 by CK2 suppresses dendritic cell function.

  2022cites this paper
• Nutrient sensitive protein O-GlcNAcylation modulates the transcriptome through epigenetic mechanisms during embryonic neurogenesis

  2022cites this paper
• Mechanisms of Polycomb group protein function in cancer

  2022cites this paper
• Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma

  2022cites this paper
• EZH2/hSULF1 axis mediates receptor tyrosine kinase signaling to shape cartilage tumor progression

  2022cites this paper
• Genetics and Epigenetics of Bone Remodeling and Metabolic Bone Diseases

  2022cites this paper
• CDK12 activates MYC to repress miR-28-5p/EZH2 and amplifies tonic BCR signaling to promote the development of diffuse large B-cell lymphoma

  2022cites this paper
• Mechanical force-sensitive lncRNA SNHG8 inhibits osteogenic differentiation by regulating EZH2 in hPDLSCs.

  2022cites this paper
• MYPT1/PP1‐Mediated EZH2 Dephosphorylation at S21 Promotes Epithelial–Mesenchymal Transition in Fibrosis through Control of Multiple Families of Genes

  2022cites this paper
• Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities

  2022cites this paper
• Remarkable Synergy When Combining EZH2 Inhibitors with YM155 Is H3K27me3-Independent

  2022cites this paper
• Effective role of Curcumin on expression regulation of EZH2 histone methyltransferase as a dynamic epigenetic factor in osteogenic differentiation of human mesenchymal stem cells.

  2022cites this paper
• MicroRNA-101a enhances trabecular bone accrual in male mice

  2022cites this paper
• FACT subunit SUPT16H associates with BRD4 and contributes to silencing of interferon signaling

  2022cites this paper
• Polycomb repression during S/G2 phases restrain initiation of cell differentiation to the G1 phase of the cell cycle

  2022cites this paper
• Epigenetic Alterations under Oxidative Stress in Stem Cells

  2022cites this paper
• Abnormally elevated EZH2-mediated H3K27me3 enhances osteogenesis in aortic valve interstitial cells by inhibiting SOCS3 expression.

  2022cites this paper
• Ezh2 mediates epigenetic regulation of osteoclastogenesis and bone remodeling in mice

  2021cites this paper
• Histone modifications centric-regulation in osteogenic differentiation

  2021cites this paper
• Androgen-induced epigenetic modulations in the ovary.

  2021cites this paper
• ZMYND8 preferentially binds phosphorylated EZH2 to promote a PRC2-dependent to -independent function switch in hypoxia-inducible factor–activated cancer

  2021influential citation
• Chaetocin Promotes Osteogenic Differentiation via Modulating Wnt/Beta-Catenin Signaling in Mesenchymal Stem Cells

  2021cites this paper
• Knockdown of NIR Suppresses Breast Cancer Cell Proliferation via Promoting FOXO3

  2021cites this paper
• The role and mechanisms of polycomb repressive complex 2 on the regulation of osteogenic and neurogenic differentiation of stem cells

  2021cites this paper
• Multiple pharmacological inhibitors targeting the epigenetic suppressor enhancer of Zeste homolog 2 (EZH2) accelerate osteoblast differentiation.

  2021cites this paper
• Non-canonical functions of the Polycomb group protein EZH2 in breast cancer.

  2021cites this paper
• Role of EZH2 in Bone Marrow Mesenchymal Stem Cells and Immune-Cancer Interactions.

  2021cites this paper
• Epigenetic Control of Osteogenic Lineage Commitment

  2021cites this paper
• Fibronectin within Sodium Alginate Microcapsules Improved Osteogenic Differentiation of BMMSCs in Dose Dependent Manner by Targeting SP7, OCN, CDK1, ZBTB16, and Twist1 Expression

  2021cites this paper
• Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer

  2021cites this paper
• Targeting EZH2 Ameliorates the LPS-Inhibited PDLSC Osteogenesis via Wnt/β-Catenin Pathway

  2021cites this paper
• Stretch-Induced Lncrna SNHG8 Inhibits Osteogenic Differentiation by Regulating EZH2 in Hpdlscs

  2021cites this paper
• Crosstalk between histone and DNA methylation mediates bone loss in hind limb unloading.

  2021cites this paper
• Epigenetic Transgenerational Inheritance of the Effects of Obesogen Exposure

  2021cites this paper
• Titanium with nanotopography attenuates the osteoclast-induced disruption of osteoblast differentiation by regulating histone methylation.

  2021cites this paper
• The Origin of Stroma Influences the Biological Characteristics of Oral Squamous Cell Carcinoma

  2021cites this paper
• Going beyond Polycomb: EZH2 Functions in Prostate Cancer

  2021cites this paper
• Self-renewal or quiescence? Orchestrating the fate of mesenchymal stem cells by matrix viscoelasticity via PI3K/Akt-CDK1 pathway.

  2021cites this paper
• OTT_A_287464 637..651

  2021cites this paper
• Cross‐talk Between Histone and DNA Methylation Mediates Bone Loss in Hind Limb Unloading

  2021cites this paper
• DNMT3A Mutation-Induced CDK1 Overexpression Promotes Leukemogenesis by Modulating the Interaction between EZH2 and DNMT3A

  2021cites this paper
• An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer

  2021cites this paper
• Benzo[a]pyrene osteotoxicity and the regulatory roles of genetic and epigenetic factors: A review

  2021cites this paper
• Estrogen receptor alpha regulates the expression of adipogenic genes genetically and epigenetically in rat bone marrow-derived mesenchymal stem cells

  2021cites this paper
• The Roles of Epigenetics Regulation in Bone Metabolism and Osteoporosis

  2021cites this paper
• EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells

  2021cites this paper
• Epigenetic modifications of histones during osteoblast differentiation.

  2021cites this paper
• Emerging roles of metazoan cell cycle regulators as coordinators of the cell cycle and differentiation

  2020cites this paper
• EZH2/H3K27Me3 and phosphorylated EZH2 predict chemotherapy response and prognosis in ovarian cancer

  2020cites this paper
• Inhibition of CDK2 reduces EZH2 phosphorylation and reactivates ERα expression in high-grade serous ovarian carcinoma.

  2020cites this paper
• Symphony of epigenetic and metabolic regulation—interaction between the histone methyltransferase EZH2 and metabolism of tumor

  2020cites this paper
• Analysis of endothelial-to-haematopoietic transition at the single cell level identifies cell cycle regulation as a driver of differentiation

  2020cites this paper